Guest Episode
How metabolic and immune system dysfunction drive the aging process, the role of NAD, promising interventions, aging clocks, and more
Ep. #359 with Eric Verdin, M.D.
Guest Episode
A new era of longevity science: models of aging, human trials of rapamycin, biological clocks, promising compounds, and lifestyle interventions
Ep. #357 with Brian Kennedy, Ph.D.
Guest Episode
Longevity roundtable — the science of aging, geroprotective molecules, lifestyle interventions, challenges in research, and more
Ep. #333 with Steven Austad, Ph.D., Matt Kaeberlein, Ph.D., Richard Miller, M.D., Ph.D.
Guest Episode
Journal club with Andrew Huberman: the impact of light exposure on mental health and an immunotherapy breakthrough for cancer treatment
Ep. #286 with Andrew Huberman, Ph.D.
Guest Episode
Longevity drugs, aging biomarkers, and updated findings from the Interventions Testing Program (ITP)
Ep. #281 with Richard Miller M.D., Ph.D.
Podcast Episode
Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more
Ep. #272 with David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D.
Guest Episode
Journal club with Andrew Huberman: metformin as a geroprotective drug, the power of belief, and how to read scientific papers
Ep. #270 with Andrew Huberman, Ph.D.
Guest Episode
The biology of aging, rapamycin, and other interventions that target the aging process
Ep. #175 with Matt Kaeberlein, Ph.D.
Free Article
Rapamycin risks?
Free Article
How long can we live?; suggested listening
Guest Episode
The gold standard for testing longevity drugs: the Interventions Testing Program
Ep. #148 with Richard Miller, M.D., Ph.D.
Guest Episode
Rapamycin and metformin—longevity, immune enhancement, and COVID-19
Ep. #123 with Joan Mannick, M.D. & Nir Barzilai, M.D.
